|
pregnancy |
18 |
|
infants |
6 |
|
rickets |
6 |
|
serum 25-hydroxyvitamin d |
6 |
|
threatened miscarriage |
6 |
|
vitamin d |
6 |
|
b cells |
5 |
|
brief intervention |
5 |
|
chinese |
5 |
|
chorionic villi |
5 |
|
drug transporters |
5 |
|
expectant father |
5 |
|
first trimester |
5 |
|
hepatitis b |
5 |
|
immune tolerance |
5 |
|
infection |
5 |
|
maternal immune tolerance |
5 |
|
maternal-fetal interface |
5 |
|
miscarriage |
5 |
|
monocyte |
5 |
|
nicotine replacement therapy |
5 |
|
oral progestogen |
5 |
|
pd-l1 |
5 |
|
placenta |
5 |
|
placental exosome |
5 |
|
pregnancy complications |
5 |
|
pten |
5 |
|
smoking cessation |
5 |
|
spatial regulatory activity |
5 |
|
spatial transcriptomics |
5 |
|
stereo-seq |
5 |
|
t cell |
5 |
|
vaginal bleeding |
5 |
|
virus receptors |
5 |
|
antidepressants |
4 |
|
bipolar disorder |
4 |
|
congenital malformations |
4 |
|
delivery complications |
4 |
|
depression |
4 |
|
developmental delay |
4 |
|
dichorionic |
4 |
|
dydrogesterone |
4 |
|
hepatitis b virus |
4 |
|
labour |
4 |
|
mood stabilizers |
4 |
|
neonatal outcomes |
4 |
|
obstetric complications |
4 |
|
pacs1 variant |
4 |
|
prenatal care |
4 |
|
prenatal exposure |
4 |
|
progestogen |
4 |
|
randomized controlled trial |
4 |
|
schuurs‐hoeijmakers syndrome |
4 |
|
screening |
4 |
|
viral load |
4 |
|
whole exome sequencing |
4 |
|
aborted fetus |
3 |
|
cervical length measurement |
3 |
|
complication |
3 |
|
congenital |
3 |
|
continuous companion support |
3 |
|
covid-19 pandemic |
3 |
|
endometrium |
3 |
|
fibronectins |
3 |
|
gestational diabetes |
3 |
|
gynecologic ultrasound |
3 |
|
immunoprophylaxis failure |
3 |
|
induced abortion |
3 |
|
infectious disease transmission |
3 |
|
infectious disease transmission, vertical |
3 |
|
obstetric labor premature |
3 |
|
predictive value of tests |
3 |
|
pregnancy outcomes |
3 |
|
rupture of membranes |
3 |
|
sonography |
3 |
|
uterus |
3 |
|
vertical |
3 |
|
vertical transmission |
3 |
|
virus immunization |
3 |
|
abdominal surgery |
2 |
|
abortion |
2 |
|
acupuncture |
2 |
|
adenocarcinoma |
2 |
|
antibiotics |
2 |
|
antiviral therapy |
2 |
|
appendix |
2 |
|
blood examination |
2 |
|
cerclage |
2 |
|
cervical cancer |
2 |
|
cervical incompetence |
2 |
|
cervical insufficiency |
2 |
|
cervical intraepithelial neoplasia |
2 |
|
cervical length |
2 |
|
covid-19 |
2 |
|
cystic adenomatoid malformation of lung |
2 |
|
cystic endosalpingiosis |
2 |
|
death |
2 |
|
doppler |
2 |
|
endometriosis |
2 |
|
exome sequencing |
2 |
|
expectation |
2 |
|
fetal fibronectin |
2 |
|
fetal hyperthyroidism |
2 |
|
genome sequencing |
2 |
|
gynecologic disease |
2 |
|
haemorrhage |
2 |
|
hepatitis a |
2 |
|
hepatitis c |
2 |
|
hepatitis d |
2 |
|
hepatitis e |
2 |
|
human |
2 |
|
hyperglycemia |
2 |
|
hysterectomy |
2 |
|
inevitable |
2 |
|
infant |
2 |
|
intrauterine therapy |
2 |
|
iron deficiency |
2 |
|
kidney |
2 |
|
knowledge |
2 |
|
lung diseases |
2 |
|
lymphedema |
2 |
|
maternal |
2 |
|
monochorionic |
2 |
|
mortality |
2 |
|
neonatal |
2 |
|
neoplasm metastasis |
2 |
|
newborn |
2 |
|
obstetrics |
2 |
|
perception |
2 |
|
perinatal transmission |
2 |
|
phenotypic variability |
2 |
|
prediabetes |
2 |
|
pregnancy outcome |
2 |
|
pregnant women - health and hygiene |
2 |
|
prematurity |
2 |
|
preterm |
2 |
|
preterm birth |
2 |
|
preterm delivery |
2 |
|
preterm labour |
2 |
|
progesterone |
2 |
|
renal failure |
2 |
|
second trimester miscarriage |
2 |
|
selective fetal growth restriction |
2 |
|
shdra |
2 |
|
silent |
2 |
|
stillbirth |
2 |
|
structural heart defects and renal anomalies syndrome |
2 |
|
thalassemia |
2 |
|
thromboembolism |
2 |
|
thyroid-stimulating hormone receptor antibody (trab) |
2 |
|
tmem260 |
2 |
|
truncus arteriosus |
2 |
|
twins |
2 |
|
universal use |
2 |
|
vulva |
2 |
|
adult |
1 |
|
adverse effects |
1 |
|
algorithm |
1 |
|
anatomical concepts |
1 |
|
anemia |
1 |
|
anti-bacterial |
1 |
|
antibody transfer |
1 |
|
antiviral |
1 |
|
antiviral agent |
1 |
|
antiviral agents |
1 |
|
antiviral treatment |
1 |
|
article |
1 |
|
auscultation |
1 |
|
biliary atresia |
1 |
|
blood sampling |
1 |
|
bradycardia |
1 |
|
case report |
1 |
|
cesarean section |
1 |
|
childbirth |
1 |
|
children |
1 |
|
complications |
1 |
|
congenital abnormalities |
1 |
|
cystic fibrosis |
1 |
|
deceleration |
1 |
|
delivery |
1 |
|
digital |
1 |
|
doptone |
1 |
|
embryology |
1 |
|
fear of childbirth |
1 |
|
fear of childbirth postpartum |
1 |
|
fetal heart rate |
1 |
|
fetal therapy |
1 |
|
fetal ultrasound |
1 |
|
fetoscopic laser ablation |
1 |
|
fetus |
1 |
|
gallbladder |
1 |
|
glycosuria |
1 |
|
gonadotropin-releasing hormone |
1 |
|
haematoma |
1 |
|
hematoma |
1 |
|
hysterectomy, vaginal |
1 |
|
icd-pm |
1 |
|
ileal atresia |
1 |
|
immunization |
1 |
|
infection transmission |
1 |
|
inflammation |
1 |
|
intellectual disability |
1 |
|
international classification of diseases |
1 |
|
intracranial haemorrhage |
1 |
|
intrapartum |
1 |
|
jejunal atresia |
1 |
|
kabuki syndrome |
1 |
|
ketonuria |
1 |
|
macrophage polarization |
1 |
|
mapk signaling pathway |
1 |
|
mastitis |
1 |
|
maternal outcomes: fetal outcomes |
1 |
|
maternal–foetal |
1 |
|
medical microbiology |
1 |
|
medulla tetrapanacis |
1 |
|
microarray analysis |
1 |
|
microbiome |
1 |
|
mode of birth |
1 |
|
mother-to-child transmission |
1 |
|
necrotising enterocolitis |
1 |
|
normal |
1 |
|
oliguria |
1 |
|
ovariectomy |
1 |
|
pathogenic cnvs |
1 |
|
perinatal mortality |
1 |
|
portable electronic applications |
1 |
|
postpartum |
1 |
|
pre-eclampsia |
1 |
|
prenatal diagnosis |
1 |
|
prenatal phenotype |
1 |
|
prenatal ultrasonography |
1 |
|
proteinuria |
1 |
|
reliability |
1 |
|
sars-cov-2 |
1 |
|
seroprevalence |
1 |
|
severe covid-19 |
1 |
|
smartphone |
1 |
|
spontaneous |
1 |
|
subdural haematoma |
1 |
|
tachycardia |
1 |
|
telehealth |
1 |
|
telemedicine |
1 |
|
twin-to-twin transfusion syndrome |
1 |
|
ultrasonography |
1 |
|
uncomplicated |
1 |
|
urinary bladder neck obstruction |
1 |
|
vaccination |
1 |
|
vaccine |
1 |
|
validity |
1 |
|
virtual clinics |
1 |
|
w-deq |
1 |
